Loading...
Respiri Limited
RSH.AX•ASX
Healthcare
Medical - Devices
A$0.03
A$0.00(0.00%)
Respiri Limited (RSH.AX) Financial Performance & Income Statement Overview
Review Respiri Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
547.80%
↑ 547.80%
Operating Income Growth
-10.21%
↓ 10.21%
Net Income Growth
-23.44%
↓ 23.44%
Operating Cash Flow Growth
-47.91%
↓ 47.91%
Operating Margin
-408.65%
↓ 408.65%
Gross Margin
83.61%
↑ 83.61%
Net Profit Margin
-408.98%
↓ 408.98%
ROE
-203.41%
↓ 203.41%
ROIC
-154.17%
↓ 154.17%
Respiri Limited (RSH.AX) Income Statement & Financial Overview
Review Respiri Limited's (RSH.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $309466.00 | $147448.00 | $60690.00 | $9843.00 |
| Cost of Revenue | $220.00 | $2.10M | $1.32M | $1.20M |
| Gross Profit | $309246.00 | -$1.95M | -$1.25M | -$1.19M |
| Gross Profit Ratio | $1.00 | -$13.23 | -$20.67 | -$121.08 |
| R&D Expenses | $67367.00 | $69765.00 | $48218.00 | $329507.00 |
| SG&A Expenses | $4.21M | $1.69M | $1.88M | $1.65M |
| Operating Expenses | $4.27M | $1.76M | $1.93M | $1.97M |
| Total Costs & Expenses | $4.28M | $3.85M | $3.25M | $3.18M |
| Interest Income | $0.00 | $1781.00 | $2804.00 | $1436.00 |
| Interest Expense | $0.00 | $65015.00 | $15000.00 | $0.00 |
| Depreciation & Amortization | -$74941.00 | $89264.00 | $37259.00 | $40034.00 |
| EBITDA | -$4.01M | -$3.58M | -$3.15M | -$3.09M |
| EBITDA Ratio | -$12.97 | -$24.53 | -$51.87 | -$317.62 |
| Operating Income | -$3.97M | -$3.71M | -$3.19M | -$3.17M |
| Operating Income Ratio | -$12.81 | -$25.13 | -$52.49 | -$321.69 |
| Other Income/Expenses (Net) | $23890.00 | -$26635.00 | -$12198.00 | $38036.00 |
| Income Before Tax | -$3.94M | -$3.73M | -$3.20M | -$3.13M |
| Income Before Tax Ratio | -$12.74 | -$25.31 | -$52.69 | -$317.83 |
| Income Tax Expense | $0.00 | -$545003.00 | $1.00 | -$550730.00 |
| Net Income | -$3.94M | -$3.19M | -$3.20M | -$2.58M |
| Net Income Ratio | -$12.74 | -$21.62 | -$52.69 | -$261.87 |
| EPS | -$0.004 | -$0.004 | -$0.004 | -$0.003 |
| Diluted EPS | -$0.004 | -$0.004 | -$0.004 | -$0.003 |
| Weighted Avg Shares Outstanding | $1.13B | $905.57M | $828.89M | $780.26M |
| Weighted Avg Shares Outstanding (Diluted) | $1.13B | $905.57M | $828.89M | $780.26M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan